Literature DB >> 1603202

Primary Sjögren's syndrome: clinical spectrum and mode of presentation based on an analysis of 50 patients selected from a department of rheumatology.

H M Markusse1, M Oudkerk, T M Vroom, F C Breedveld.   

Abstract

In this study we report on the clinical characteristics at the time of referral and during follow-up of 50 patients with primary Sjögren's syndrome (SS) in a rheumatological practice. The mean age of the patients at the time of diagnosis was 51.5 years. Four of them were men and 46 women. During a mean follow-up period of 9.1 yr (1-21 yr) from symptom onset the most common signs and symptoms were arthralgia (94%), complaints of dryness of the eyes (90%), mouth (82%) and skin (56%), weariness (64%), exanthema (48%), Raynaud's phenomenon (42%) and arthritis (42%). An elevated erythrocyte sedimentation rate (72%), elevated serum gammaglobulin (49%) and leucocytopenia (42%) were the most frequently encountered abnormalities of routine laboratory tests. After the initial hospital evaluation the diagnosis primary SS was made in only 10 (20%) of the patients. The diagnostic delay was on average 3.1 yr. Knowledge of the considerable heterogeneity of the disease may prevent extensive evaluations and provide better clinical care for patients with primary SS.

Entities:  

Mesh:

Year:  1992        PMID: 1603202

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  10 in total

Review 1.  CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.

Authors:  M Govoni; M Padovan; N Rizzo; F Trotta
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Neutropenia in the Elderly: A Rheumatology Perspective.

Authors:  Su-Ann Yeoh; Christine Fox; Richard Hull
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

3.  A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects.

Authors:  M Pertovaara; E Pukkala; P Laippala; A Miettinen; A Pasternack
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

4.  Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both).

Authors:  M Pertovaara; M Korpela; H Uusitalo; J Pukander; A Miettinen; H Helin; A Pasternack
Journal:  Ann Rheum Dis       Date:  1999-07       Impact factor: 19.103

5.  Prevalence of Novel Candidate Sjögren Syndrome Autoantibodies in the Penn Sjögren's International Collaborative Clinical Alliance Cohort.

Authors:  Vatinee Y Bunya; Mina Massaro-Giordano; Frederick B Vivino; Maureen G Maguire; Alan N Baer; John A Gonzales; Gui-Shuang Ying
Journal:  Cornea       Date:  2019-12       Impact factor: 2.651

6.  Leucocytoclastic vasculitis as presenting feature of primary Sjögren's syndrome.

Authors:  H M Markusse; M Schoonbrood; M Oudkerk; S C Henzen-Logmans
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

7.  Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndrome.

Authors:  Barbara Segal; William Thomas; Tyson Rogers; Joanlise M Leon; Pamela Hughes; Danielle Patel; Ketan Patel; Jill Novitzke; Michael Rohrer; Rajaram Gopalakrishnan; Sandra Myers; Abu Nazmul-Hossain; Eshrat Emamian; Andrew Huang; Nelson Rhodus; Kathy Moser
Journal:  Arthritis Rheum       Date:  2008-12-15

8.  Spontaneous intracranial hemorrhage as an initial manifestation of primary Sjögren's syndrome: a case report.

Authors:  Guo-Qiang Wang; Wei-Wei Zhang
Journal:  BMC Neurol       Date:  2013-07-29       Impact factor: 2.474

Review 9.  Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  BMC Med       Date:  2015-02-06       Impact factor: 8.775

10.  Clinical and laboratory features of primary Sjögren's syndrome complicated with mild to severe thrombocytopenia.

Authors:  Jian Wu; Xin Chang; Jian Zhang; Cuiping Liu; Mingxing Liu; Weichang Chen
Journal:  Ann Transl Med       Date:  2022-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.